Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Intestinal epithelial toxin A receptor complex refers to the assembly of host cell surface molecules, such as sucrase-isomaltase (SI), glycoprotein 96 (gp96), and the nerve growth factor receptor (p75NTR), that mediate the binding and internalization of Clostridioides difficile Toxin A (TcdA) (Pothoulakis et al., 1996; Na et al., 2008; Yuan et al., 2015). TcdA is a potent enterotoxin and a primary virulence factor in C. difficile infections, causing significant mucosal damage, inflammation, and fluid secretion (Gerhard, 2017). The receptor complex facilitates the endocytosis of TcdA, which subsequently glucosylates host Rho-family GTPases, leading to the collapse of the actin cytoskeleton and disruption of the intestinal barrier (Voth & Ballard, 2005). This molecular cascade results in the clinical symptoms of pseudomembranous colitis and severe diarrhea (Kelly & LaMont, 2008). Therapeutic strategies have focused on neutralizing TcdA using monoclonal antibodies like actoxumab to prevent its association with these receptors (Lowy et al., 2010). Although actoxumab was developed to target this interaction, clinical success has been more pronounced with therapies targeting Toxin B, reflecting the complex synergy between the two toxins in human disease (Wilcox et al., 2017).
Neutralization of Toxin A to prevent its interaction with host cell surface receptors and subsequent internalization into enterocytes.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clostridioides difficile Toxin A receptor complex (TcdA receptor complex).